{"title":"Is the NHS ready for new Alzheimer's disease treatments?","authors":"M. Greener","doi":"10.1002/psb.2078","DOIUrl":null,"url":null,"abstract":"New effective treatments for Alzheimer's disease have eluded researchers for many years, but promising pharmacotherapies may at last be approaching clinical approval. This article examines some of these new treatments, their modes of action and the practicalities of implementation once they reach the market.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2078","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
New effective treatments for Alzheimer's disease have eluded researchers for many years, but promising pharmacotherapies may at last be approaching clinical approval. This article examines some of these new treatments, their modes of action and the practicalities of implementation once they reach the market.